Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 20 studies | 28% ± 13% | |
| ciliated cell | 16 studies | 33% ± 11% | |
| oligodendrocyte | 16 studies | 51% ± 19% | |
| fibroblast | 14 studies | 23% ± 8% | |
| naive B cell | 13 studies | 23% ± 6% | |
| type II pneumocyte | 12 studies | 47% ± 14% | |
| B cell | 12 studies | 22% ± 4% | |
| astrocyte | 12 studies | 30% ± 14% | |
| epithelial cell | 11 studies | 33% ± 16% | |
| type I pneumocyte | 10 studies | 34% ± 20% | |
| oligodendrocyte precursor cell | 9 studies | 33% ± 13% | |
| adipocyte | 9 studies | 25% ± 7% | |
| glutamatergic neuron | 8 studies | 54% ± 25% | |
| macrophage | 8 studies | 25% ± 8% | |
| memory B cell | 8 studies | 19% ± 3% | |
| club cell | 8 studies | 37% ± 15% | |
| GABAergic neuron | 7 studies | 44% ± 23% | |
| neuron | 6 studies | 33% ± 17% | |
| microglial cell | 6 studies | 27% ± 6% | |
| smooth muscle cell | 6 studies | 21% ± 2% | |
| glial cell | 5 studies | 23% ± 5% | |
| interneuron | 5 studies | 47% ± 24% | |
| pericyte | 5 studies | 23% ± 6% | |
| CD8-positive, alpha-beta T cell | 5 studies | 17% ± 2% | |
| respiratory goblet cell | 5 studies | 28% ± 11% | |
| ionocyte | 4 studies | 25% ± 4% | |
| squamous epithelial cell | 4 studies | 37% ± 19% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 18% ± 3% | |
| precursor B cell | 4 studies | 28% ± 3% | |
| retina horizontal cell | 4 studies | 30% ± 4% | |
| abnormal cell | 4 studies | 22% ± 6% | |
| natural killer cell | 4 studies | 18% ± 2% | |
| monocyte | 4 studies | 24% ± 7% | |
| endothelial cell of lymphatic vessel | 4 studies | 22% ± 3% | |
| basal cell | 4 studies | 27% ± 11% | |
| plasmacytoid dendritic cell | 4 studies | 18% ± 3% | |
| gamma-delta T cell | 4 studies | 19% ± 3% | |
| conventional dendritic cell | 3 studies | 19% ± 2% | |
| plasmablast | 3 studies | 28% ± 8% | |
| granule cell | 3 studies | 27% ± 9% | |
| progenitor cell | 3 studies | 28% ± 9% | |
| placental villous trophoblast | 3 studies | 39% ± 20% | |
| mucosal invariant T cell | 3 studies | 17% ± 1% | |
| myeloid cell | 3 studies | 18% ± 1% | |
| immature B cell | 3 studies | 26% ± 5% | |
| amacrine cell | 3 studies | 30% ± 9% | |
| Mueller cell | 3 studies | 19% ± 3% | |
| rod bipolar cell | 3 studies | 18% ± 0% | |
| mast cell | 3 studies | 16% ± 0% | |
| secretory cell | 3 studies | 23% ± 2% | |
| endothelial cell of vascular tree | 3 studies | 23% ± 7% | |
| myofibroblast cell | 3 studies | 24% ± 8% | |
| dendritic cell | 3 studies | 23% ± 6% | |
| alveolar macrophage | 3 studies | 23% ± 8% | |
| Schwann cell | 3 studies | 40% ± 15% | |
| goblet cell | 3 studies | 32% ± 20% | |
| T cell | 3 studies | 22% ± 9% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 8827.11 | 2642 / 2642 | 100% | 56.34 | 703 / 705 |
| prostate | 100% | 4123.23 | 244 / 245 | 99% | 38.33 | 496 / 502 |
| esophagus | 100% | 4315.28 | 1443 / 1445 | 98% | 18.53 | 180 / 183 |
| kidney | 100% | 3234.04 | 89 / 89 | 98% | 32.78 | 879 / 901 |
| thymus | 100% | 5396.29 | 653 / 653 | 97% | 31.09 | 589 / 605 |
| lung | 100% | 5800.19 | 576 / 578 | 98% | 23.46 | 1128 / 1155 |
| breast | 100% | 4547.08 | 459 / 459 | 96% | 26.94 | 1078 / 1118 |
| adrenal gland | 100% | 4262.16 | 258 / 258 | 96% | 21.27 | 220 / 230 |
| skin | 100% | 3568.56 | 1804 / 1809 | 94% | 35.81 | 444 / 472 |
| ovary | 100% | 4201.97 | 180 / 180 | 92% | 14.23 | 396 / 430 |
| pancreas | 96% | 1888.47 | 314 / 328 | 96% | 17.69 | 170 / 178 |
| stomach | 100% | 3653.28 | 359 / 359 | 90% | 14.39 | 258 / 286 |
| uterus | 100% | 4705.98 | 170 / 170 | 86% | 12.44 | 396 / 459 |
| bladder | 100% | 4016.14 | 21 / 21 | 85% | 12.54 | 427 / 504 |
| intestine | 100% | 4177.19 | 966 / 966 | 84% | 12.23 | 441 / 527 |
| liver | 96% | 1732.74 | 218 / 226 | 72% | 9.31 | 293 / 406 |
| blood vessel | 100% | 5369.16 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 4761.60 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2666.41 | 240 / 241 | 0% | 0 | 0 / 0 |
| muscle | 98% | 2442.14 | 790 / 803 | 0% | 0 | 0 / 0 |
| heart | 92% | 2348.23 | 792 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 76% | 9.71 | 34 / 45 |
| eye | 0% | 0 | 0 / 0 | 75% | 14.49 | 60 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 69% | 11.16 | 20 / 29 |
| peripheral blood | 30% | 1444.45 | 282 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0001514 | Biological process | selenocysteine incorporation |
| GO_1990904 | Cellular component | ribonucleoprotein complex |
| GO_0043021 | Molecular function | ribonucleoprotein complex binding |
| GO_0003730 | Molecular function | mRNA 3'-UTR binding |
| GO_0035368 | Molecular function | selenocysteine insertion sequence binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | SECISBP2L |
| Protein name | Selenocysteine insertion sequence-binding protein 2-like (SECIS-binding protein 2-like) SECIS binding protein 2 like |
| Synonyms | KIAA0256 |
| Description | FUNCTION: Binds SECIS (Sec insertion sequence) elements present on selenocysteine (Sec) protein mRNAs, but does not promote Sec incorporation into selenoproteins in vitro. |
| Accessions | ENST00000559424.1 J3KPI1 H0YKY4 H0YNT4 ENST00000559471.6 [Q93073-1] Q93073 ENST00000261847.7 [Q93073-2] ENST00000380927.6 ENST00000561428.1 |